Cell Source, Inc.
OTC:CLCS
0.4975 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0.001 | -0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 1.578 | 1.996 | 1.323 | 0.999 | 2.63 | 0.725 | 1.477 | 1.367 | 1.223 | 1.819 | 0.001 | 0.001 |
| General & Administrative Expenses
| 2.605 | 2.179 | 2.695 | 2.639 | 1.175 | 1.281 | 0.001 | 0 | 0 | 0 | 0.026 | 0 |
| Selling & Marketing Expenses
| -2,604,748.395 | 0 | 0 | 0 | 0 | 0 | 0.815 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.605 | 2.179 | 2.695 | 2.639 | 1.175 | 1.281 | 0.816 | 0.952 | 1.098 | 2.236 | 0.026 | 0 |
| Other Expenses
| 0.143 | 58,000 | 0.05 | 163,611 | -0.224 | -0.191 | -0.725 | 0 | 829,970 | 1,012,464 | 0 | 0 |
| Operating Expenses
| 4.325 | 4.175 | 4.019 | 3.638 | 3.805 | 2.006 | 2.293 | 2.319 | 2.32 | 4.055 | 0.026 | 0.002 |
| Operating Income
| -4.325 | -4.175 | -4.019 | -3.638 | -3.805 | -2.006 | -2.293 | -2.319 | -2.32 | -4.055 | -0.026 | -0.002 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.996 | -992,415 | -1.454 | -0.922 | -0.67 | 0.367 | -0.563 | 1.632 | -0.148 | -0.003 | -0 | 0 |
| Income Before Tax
| -5.321 | -5.168 | -5.472 | -4.56 | -4.475 | -2.117 | -3.083 | -0.968 | -2.504 | -4.057 | -0.026 | -0.002 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.168 | -992,414.012 | 1.361 | 0.937 | 0.308 | 0.479 | -0.336 | -0.957 | 0.036 | 0 | -0.002 | 0 |
| Net Income
| -5.321 | -5.168 | -6.833 | -5.498 | -4.783 | -2.117 | -3.083 | -0.968 | -2.504 | -4.057 | -0.026 | -0.002 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.17 | -0.15 | -0.21 | -0.19 | -0.17 | -0.077 | -0.12 | -0.037 | -0.097 | -0.18 | -0.002 | -0.14 |
| EPS Diluted
| -0.14 | -0.15 | -0.21 | -0.19 | -0.17 | -0.077 | -0.12 | -0.037 | -0.097 | -0.18 | -0.002 | -0.14 |
| EBITDA
| -2.367 | -4.175 | -3.969 | -3.638 | -4.029 | -2.197 | -3.407 | -3.556 | -2.32 | -4.054 | -0.026 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |